CBL-514 Isn’t a Peptide: How It Compares to AOD-9604 and Other Fat-Loss Peptides
CBL-514 is making waves in fat-reduction research, but despite showing up in peptide conversations, it isn’t a peptide. In this episode of The Peptide Effect, we explain what it is, how it differs from AOD-9604, and how peptides like tesamorelin, semaglutide, tirzepatide, and retatrutide fit into the discussion. Discover the differences between targeted fat reduction, visceral fat reduction, and overall weight loss—and what the research actually supports.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.